Skip to main content

Advertisement

Table 4 Endorsed Symptoms During Interviews at Different Stages of Patient Diagnosis

From: Identifying symptom recurrences in primary brain tumor patients using the MDASI-BT and qualitative interviews

Symptoms reported N (%)
Pre-surgeryb
 Seizures 10 (45%)
 Pain 8 (36%)
 Difficulty Speaking 3 (14%)
 Night sweatsa 1 (9%)
 Hand tremorsa 1 (9%)
 Tongue spasmsa 1 (9%)
After surgeryb
 Weakness 2 (25%)
 Pain 2 (25%)
 Difficulty sleeping 2 (25%)
 Noise sensitivitya 1 (13%)
 Tremorsa 1 (13%)
 Food cravingsa 1 (13%)
During Treatmentb
 Fatigue 8 (47%)
 Hair loss 6 (35%)
 Nausea 6 (35%)
 Itchinga 2 (12%)
 Swellinga 2 (12%)
 Muscles achesa 1 (6%)
After Treatmentb
 Numbness/tingling 1 (100%)
 Foot crampsa 1 (100%)
 Difficulty stretchinga 1 (100%)
Recurrenceb
 Numbness 1 (50%)
 Walking 1 (50%)
 Seizures 1 (50%)
  1. aSymptoms not represented in the MDASI-BT
  2. b For each stage, the following represents, the total number of MDASI(M)/NON MDASI (NM) symptoms reported and symptoms not included in the table: Pre-surgery (11 M, memory issues, nausea, difficulty understanding, difficulty walking, difficulty concentrating, fatigue, vision, numbness, 7NM: dizziness, withdrawing, difficulty moving body parts, crushing in throat), After-surgery (9 M, difficulty understanding, irritability, difficulty walking, numbness, vision, memory issues, 4NM, sneezing changes), During Treatment (14 M, pain, unable to speak, mood changes, difficulty walking, weakness, numbness/tingling, vision, change in bowel pattern, difficulty remembering, difficulty concentrating, memory issues, 8NM, decreased sex drive, crustiness on lips, increased appetite, weakness of voice, shakiness), After Treatment (1 M, 2NM), Recurrence (3 M, 0NM)